Colorectal Neoplasms: all 5,738 studies
Page 46 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Capsule Versus Conventional Colonoscopy in Patient Following Colorectal SurgeryTerminatedNCT01879943Not applicable
- Evaluation of Endoscopic Submucosal Dissection (ESD) EfficacyCompletedNCT01879904Not applicable
- Sequential Treatment Strategy for Metastatic Colorectal CancerCompletedNCT01878422Phase 3
- Motivational Interviewing for ColonoscopyCompletedNCT01877096Not applicable
- Colorectal Cancer Screening in Primary CareCompletedNCT01877018Not applicable
- Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal CancerCompletedNCT01875380Phase 2
- Clinical Study to Establish the Feasibility and Usability of the EndoRings™CompletedNCT01868971Not applicable
- Nordic 8 - A Phase II TrialCompletedNCT01867697Phase 2
- Epidemiological Study of Colorectal Cancer in WuHanStatus unknownNCT01863303
- Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer PatientsStatus unknownNCT01862562Phase 3
- Phase I/II Trial of Antagonism of HER in GI CancerCompletedNCT01862003Phase 2
- An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal CancerStatus unknownNCT01860144
- Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid TumorsCompletedNCT01859858Phase 1
- Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT TumorsTerminatedNCT01858662Phase 2
- Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.CompletedNCT01858649Phase 2
- First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal CancerCompletedNCT01853813Phase 2
- Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard TherapyCompletedNCT01853319Phase 3
- Ohio Colorectal Cancer Prevention InitiativeCompletedNCT01850654Not applicable
- Educational Intervention to Adherence of Patients Treated by Capecitabine +/- LapatinibTerminatedNCT01847599Not applicable
- Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver MetastasisWithdrawnNCT01847495Not applicable
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersCompletedNCT01843725Phase 1
- Regorafenib Post-marketing SurveillanceCompletedNCT01843400
- ALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver MetastasisTerminatedNCT01842971Phase 3
- NK Activity Modulation Induced by Intravenous Lidocaine During Colorectal Laparoscopic SurgeryStatus unknownNCT01841294Phase 4
- Study of DC-CIK to Treat Colorectal CancerStatus unknownNCT01839539Phase 2
- Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesCompletedNCT01836653Phase 2
- Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy SubjectsCompletedNCT01834742Phase 1
- Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesCompletedNCT01834014Not applicable
- Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal CancerStatus unknownNCT01832948Phase 2
- Cetuximab Rechallenge StudyCompletedNCT01832467Phase 2
- Nutrition for Colorectal Cancer Patients and Neutrophil FunctionsCompletedNCT01831310Phase 4
- Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal CancersStatus unknownNCT01828918Phase 1
- ANGIOPREDICT. ICORG 12-16, V3CompletedNCT01822444
- Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseCompletedNCT01819766
- An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to MetforminTerminatedNCT01816659Phase 1
- Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation ProjectStatus unknownNCT01815879
- ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal MetastasisActive, not recruitingNCT01815359Phase 2
- Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal CancerCompletedNCT01811108
- Educational Program to Increase Colorectal Cancer Screening: a Cluster TrialStatus unknownNCT01805622Not applicable
- RCT to Examine the Effects of ScanningCompletedNCT01804621Not applicable
- Colorectal Cancer Awareness, Research, Education and Screening (CARES)CompletedNCT01804179Not applicable
- Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment ToolCompletedNCT01803009Not applicable
- OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal CancerCompletedNCT01802684Phase 2
- A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal CancerStatus unknownNCT01801904Phase 2
- Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil RegimensTerminatedNCT01801085
- NSABP Patient Registry and Biospecimen Profiling RepositoryCompletedNCT01793805
- Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian PopulationCompletedNCT01793207
- Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in EuropeCompletedNCT01791361
- NovellusDx Tissue Collection ProtocolCompletedNCT01791322
- Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal CancerCompletedNCT01791309Phase 1
- BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01791140
- Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic BubblesCompletedNCT01790139Not applicable
- Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryCompletedNCT01787500Phase 1
- Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus FluoropyrimidinesWithdrawnNCT01786538Phase 3
- Colon Cancer Study of Fecal Samples in Shanghai, ChinaCompletedNCT01778595
- An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)CompletedNCT01775644
- CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer ScreeningCompletedNCT01773980
- Non-cathartic Computed Tomographic Colonography to Screen Subjects With a Family History of Colorectal CancerCompletedNCT01766479Not applicable
- Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal CancerStatus unknownNCT01763450Phase 2
- A Study of Famitinib in Patients With Advanced Colorectal CancerCompletedNCT01762293Phase 2
- Chemoradiotherapy for Patients With Oligometastatic Colorectal CancerTerminatedNCT01759238Phase 2
- Pilot Evaluation of Fecal Immunologic Test (FIT) in OntarioCompletedNCT01754896Not applicable
- Inclusion of Elderly Patients With Colorectal Cancer in Clinical TrialsCompletedNCT01754636
- A Non-Interventional Follow-Up to the VELOUR Study - Translational ResearchStatus unknownNCT01754272
- Safety and Efficacy of the NaviAid™ G-Eye System During ColonoscopyCompletedNCT01749722Not applicable
- PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening ProgramStatus unknownNCT01744509Not applicable
- Improving Rates of Colorectal Cancer Screening Among Never Screened PatientsCompletedNCT01742169Not applicable
- AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal CancerWithdrawnNCT01741038Phase 2/3
- Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?TerminatedNCT01740947Phase 4
- Participation and Detection Rate of Screening CT Colonography and Screening SigmoidoscopyCompletedNCT01739608Not applicable
- wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer PatientsStatus unknownNCT01736904Phase 2
- CCR5-blockade in Metastatic Colorectal CancerCompletedNCT01736813
- Prehabilitation to Overcome the Stress of Surgery: the Role of Nutrition in Enhancing Postoperative Functional CapacityCompletedNCT01727570Not applicable
- Informativeness to Digital Rectal ExaminationCompletedNCT01727388Phase 3
- Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4TerminatedNCT01726309
- Screening Platform for Clinical Trials in Advanced Colorectal CancerCompletedNCT01723969
- Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal CancerCompletedNCT01722903
- Phase I Platinum Based Chemotherapy Plus IndomethacinCompletedNCT01719926Phase 1
- Cetuximab for Elderly Patients With mCRCTerminatedNCT01718808Phase 2
- Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal CancerTerminatedNCT01715363Phase 2
- Quantifying Micro RNA Levels of ColonStatus unknownNCT01712958
- An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal CancerCompletedNCT01712347
- Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening StrategiesCompletedNCT01710215Not applicable
- Diet and Physical Activity Intervention in CRC SurvivorsStatus unknownNCT01708824Phase 2
- The Investigation of the EtCO₂- PaCO₂ Relation During Laparoscopic Colon SurgeryStatus unknownNCT01707511
- The Impact of Physical Activity on the Outcome of SurgeryCompletedNCT01707121
- Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.CompletedNCT01705002Phase 1
- Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive TechniquesCompletedNCT01704703Phase 2
- Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the TherapeuticCompletedNCT01703910Phase 2
- Feasibility Study of Genomic Profiling Methods and Timing in Tumor SamplesCompletedNCT01703585
- Biomarker Directed Treatment in Metastatic Colorectal CancerCompletedNCT01703390Phase 2
- IVICA: Intravenous Iron in Colorectal Cancer Associated AnaemiaCompletedNCT01701310Phase 4
- Developing Objective Fatigue Indicators in Colorectal Cancer Survivors.Status unknownNCT01700283Not applicable
- Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT01700062Phase 4
- Xenon Combined With Intraoperative Thoracic Epidural AnalgesiaCompletedNCT01696630Phase 2
- A Randomized Trial on the Technical Aspects of Stoma Construction.CompletedNCT01694238Not applicable
- "Cancersensor" ChemotherapyCompletedNCT01693861
- "Cancersensor" Metastasis ResectionCompletedNCT01693848
- "Cancersensor": Circadian RhythmsCompletedNCT01693835